Bavachinin, as a novel natural pan-PPAR agonist, exhibits unique synergistic effects with synthetic PPAR-γ and PPAR-α agonists on carbohydrate and lipid metabolism in db/db and diet-induced obese mice

Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice

(2014) Yu Zhang et al.   Scientific Reports

Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases

(2013) Francisco A. Monsalve et al.   MEDIATORS OF INFLAMMATION

The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists

(2012) Azadeh Matin et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Amorfrutins are potent antidiabetic dietary natural products

(2012) C. Weidner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation

(2011) Jang Hyun Choi et al.   NATURE

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5

(2010) Jang Hyun Choi et al.   NATURE

7-Hydroxy-benzopyran-4-one Derivatives: A Novel Pharmacophore of Peroxisome Proliferator-Activated Receptor α and -γ (PPARα and γ) Dual Agonists

(2009) Azadeh Matin et al.   JOURNAL OF MEDICINAL CHEMISTRY

Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet

(2009) Caroline Fernandes-Santos et al.   NUTRITION